Stay updated on Dasotraline's Efficacy in Adult ADHD: Clinical Trial
Sign up to get notified when there's something new on the Dasotraline's Efficacy in Adult ADHD: Clinical Trial page.

Latest updates to the Dasotraline's Efficacy in Adult ADHD: Clinical Trial page
- ChecktodayChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer release of the page template/CMS. This update is a backend/version change and does not modify the study content presented on the page.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing the previous Revision: v3.5.2 in the site’s revision history. It represents a software release update and does not modify the study content or data on the page.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded the 2026 Clin Drug Investig publication by Gumenyuk et al. and updated the revision to v3.5.2. The older online-ahead-of-print reference was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision tag updated to v3.4.3 on the page, replacing the previous v3.4.2.SummaryDifference0.0%

- Check86 days agoChange DetectedAdded a new related publication to the Publications section: Gumenyuk S. et al., Characterization of the Safety Profile of the Triple Monoamine Reuptake Inhibitor Dasotraline, Clin Drug Investig. 2026 (online ahead of print).SummaryDifference0.0%

Stay in the know with updates to Dasotraline's Efficacy in Adult ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dasotraline's Efficacy in Adult ADHD: Clinical Trial page.